Position in NVS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$9,021,565
+$3,449,965 QoQ
Shares Held
59,061
+46.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BESSEMER GROUP INC holds $1,930,382,582 across 16 Drug Manufacturers - General names. NVS ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
860,704 | $791,649,710 | |
| 2 | ABBV |
AbbVie Inc.
|
3,157,936 | $686,819,495 | |
| 3 | PFE |
Pfizer Inc
|
5,165,091 | $145,035,748 | |
| 4 | JNJ |
Johnson & Johnson
|
542,749 | $132,669,559 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,081,897 | $130,141,384 | |
| 6 | AMGN |
Amgen Inc
|
32,013 | $11,263,769 | |
| 7 | NVS |
Novartis AG
This page
|
59,061 | $9,021,565 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
64,184 | $8,945,321 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,021,565 | 59,061 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $5,571,600 | 40,412 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $2,048,759 | 15,976 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,884,487 | 15,573 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $1,258,496 | 11,289 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $991,002 | 10,184 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,308,236 | 11,374 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,321,592 | 12,414 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,216,184 | 12,573 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $1,511,621 | 14,971 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,498,154 | 14,708 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,653,205 | 16,383 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,432,900 | 15,575 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,539,244 | 16,967 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,671,914 | 21,996 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $1,507,759 | 17,837 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,588,097 | 18,098 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,771,354 | 20,251 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $1,764,319 | 21,574 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,013,209 | 22,065 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,817,474 | 21,262 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,385,096 | 14,668 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,246,483 | 14,334 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,205,989 | 13,808 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,210,448 | 14,681 | Shares | Defined | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||